Cengiz CENGİSİZ, Ufuk BAL, Kemal Türker ULUTAŞ, Nebile DAĞLIOĞLU

Peyote kaktüsü yoluyla meskalin kötüye kullanımı: Türkiye'de ilk olgu sunumu

Meskalin, doğal nörotransmitter olan epinefrin ve dopamine benzer bir psikoaktif halüsinojenik alkaloiddir. Meskalin, peyote kaktüsünden elde edilir. Peyote kaktüsü rutin toksikoloji laboratuvarlarında kan veya idrar örneklerinde saptanamaz ve internet üzerinden kolayca sağlanabilir. Bu olgu sunumunda, Türkiye'de peyote kaktüsü yoluyla meskalin kötüye kullanan ilk olgu sunulmuştur. On sekiz yaşında bir erkek hasta, üç aydır esrar kullanması nedeniyle mahkeme kararı ile denetimli serbestlik hizmeti alması için hastanemize gönderilmişti ve adli psikiyatri polikliniğimizde tedavi edilmekte idi. Acil servisimize yoğun anksiyete, panik atak ve görsel varsanılar gibi belirtilerle başvurdu. Hasta, idrar tetkikinde esrar kullandığının anlaşılmaması için peyote kaktüsü kullandığını belirtti. (Anadolu Psikiyatri Derg 2016; 17(Ek.3):68-70).

Mescaline abuse via peyote cactus: the first case report in Turkey

Mescaline is a psychoactive hallucinogenic alkaloid that resemble the natural neurotransmitters epinephrine and dopamine. It is extracted from peyote cactus. Peyote cactus cannot be detected via blood or urine samples in routine toxicology laboratories, and it can be easily reachable over the Internet. In this report, we presented the first case of mescaline abuse via peyote cactus in Turkey. The case is an 18-year-old male patient. He was subjected to probation service due to use of cannabis for three months by the court decision, and being treated in our forensic outpatient clinic. He was admitted to the emergency service with symptoms such as intense anxiety, panic attacks and visual hallucinations. Patient told that he consumed peyote cactus instead using cannabis not to get caught in urine analyze. (Anatolian Journal of Psychiatry 2016; 17(Suppl.3):68-70).

___

1. Bruhn JG, De Smet PA, El-Seedi HR, Beck O. Mescaline use for 5700 years. Lancet 2002; 359(9320):1866.

2. Colace C. Drug dreams in mescaline and LSD addiction. The American Journal on Addictions/ American Academy of Psychiatrists in Alcoholism and Addictions 2010; 19(2):192.

3. Halpern JH. Hallucinogens and dissociative agents naturally growing in the United States. Pharmacology & Therapeutics 2004; 102(2):131- 138.

4. Winter JC. Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines. Psychopharmacology 2009; 203(2):251- 263.

5. Carstairs SD, Cantrell FL. Peyote and mescaline exposures: a 12-year review of a statewide poison center database. Clin Toxicol 2010; 48(4):350- 353.

6. Fickenscher A, Novins DK, Manson SM. Illicit peyote use among American Indian adolescents in substance abuse treatment: a preliminary investigation. Subst Use Misuse 2006; 41(8):1139- 1154.

7. Aras M, Altas M, Yilmaz A, Serarslan Y, Yilmaz N, Yengil E, et al. Being a neighbor to Syria: a retrospective analysis of patients brought to our clinic for cranial gunshot wounds in the Syrian civil war. Clin Neurol Neurosurg 2014; 125:222-228.

8. Arslan MM, Zeren C, Celikel A, Ortanca I, Demirkiran S. Increased drug seizures in Hatay, Turkey related to civil war in Syria. Int J Drug Policy 2015; 26(1):116-118.

9. Petekkaya S, Ayaz N, Dogan M, Oruc M, Oner BS, Gokturk C, et al. Suicidal death from pseudoephedrine sulfate overdose: a case report. Ulutas Med J 2015; 1(4):119-121.

10. Cengisiz C, Deveci A, Yapici A. Effects of depression on treatment motivation in male alcohol dependence. Arch Neuropsychiatry 2015; 52:412-416.